Truxa

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Truxa

Truxa is a prescription-only medicine whose single active compound is Levofloxacin, a synthetic compound specifically designed for high efficacy against bacterial threats. Levofloxacin is the purified L-isomer of Ofloxacin, a distinction that grants it enhanced microbiological potency and stereochemical stability.

Quick Facts Description
Active ingredient Levofloxacin
Form Film-coated tablet, Solution for infusion, Ophthalmic solution
Pharmacological class Fluoroquinolone Antibiotic (Third-generation)
General purpose Elimination of susceptible bacterial pathogens (bactericidal action)
Origin Synthetic compound

Defining the Antibiotic Class and General Purpose

Truxa is classified within the fluoroquinolone family of antibiotics, recognized as a third-generation agent, a classification clinically recognized for its strong activity against a wide range of microbial pathogens. Levofloxacin is a broad-spectrum fluoroquinolone used to treat bacterial infections. As a bactericidal agent, its general purpose is to actively kill the targeted bacteria, providing broad-spectrum coverage across various sites of infection.

To allow for varied treatment needs, Truxa is available in multiple dosage forms, including an oral tablet and a sterile solution for infusion for systemic delivery, along with a specialized ophthalmic solution for targeted local application.


Understanding the Bactericidal Mechanism

The potency of Truxa is directly linked to its function of concentration-dependent killing. The Levofloxacin compound operates by infiltrating the bacterial cell and precisely targeting its core DNA-related machinery. This mechanism involves inhibiting the key bacterial enzymes DNA gyrase and topoisomerase IV, which are essential for DNA replication and survival. This specific interference ensures the rapid and definitive elimination of the pathogen, positioning Truxa as a robust tool against established bacterial infections.

Regulatory References

  1. NIH StatPearls: Levofloxacin

What side effects are possible with Truxa?

Truxa ( Levofloxacin), a fluoroquinolone antibiotic, is associated with a range of officially documented adverse reactions classified by frequency and body system. The most common effects reported in regulatory documents, typically occurring in three percent or more of patients, include nausea, headache, diarrhea, insomnia, constipation, and dizziness.


Serious and Potentially Irreversible Adverse Reactions

Official regulatory labeling highlights the potential for disabling and potentially irreversible adverse reactions affecting multiple body systems. These include a risk of tendinitis and tendon rupture (e.g., Achilles tendon), which may occur rapidly or several months after treatment discontinuation. Effects on the nervous system include peripheral neuropathy (which may be permanent), convulsions, anxiety, depression, and psychotic reactions, sometimes reported after the first dose. Serious cardiovascular risks, such as Prolongation of the QT interval and Aortic Aneurysm and Dissection, are also documented.


Population-Specific Safety Considerations

Regulatory documents outline specific safety notes for certain patient populations:

  • Older Adults (ge 60 years): This group has an increased risk for tendon disorders and severe hepatotoxicity (liver injury).
  • Concomitant Corticosteroids: Concurrent use significantly increases the risk of tendinitis/tendon rupture.
  • Myasthenia Gravis: Use is to be avoided due to the potential for exacerbating muscle weakness.
  • Pediatrics: The medication is generally contraindicated for children and growing adolescents due to the risk of musculoskeletal injury.

Truxa is officially reserved for use in patients with no alternative treatment options for certain less severe infections (e.g., uncomplicated urinary tract infections), reflecting the need to weigh potential risks against treatment necessity.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define the manifestations and required immediate actions in the event of a Truxa (Levofloxacin) overdose. An acute overdose may result in serious manifestations primarily affecting the central nervous system and the cardiovascular system.

Documented Overdose Presentations

Clinical signs officially documented in relation to Levofloxacin overdose include convulsions (seizures), tremors, and nausea. A severe outcome noted in regulatory labeling is the risk of Prolongation of the QT interval, which may lead to life-threatening cardiac arrhythmias. Patient observation and continuous monitoring, particularly for the ECG, are mandated following an overdosage.

Official Emergency Actions

In the event of a suspected overdose, regulatory authorities require that the patient contact a poison control center or emergency room at once or seek immediate medical attention. Management for acute overdosage is strictly symptomatic and supportive treatment, as no specific antidote is known.

Supportive procedural steps described in regulatory information include maintaining appropriate hydration and performing gastric emptying, such as gastric lavage, in acute cases. Furthermore, official labeling specifies that Levofloxacin is not efficiently removed by hemodialysis or peritoneal dialysis, which is a crucial constraint for medical staff managing the overdose situation.

Therapeutic Uses of Truxa

What Truxa Treats: Main Uses and Benefits

Truxa is applied across domains where additional symptomatic support is needed for bacterial infections associated with acute or disruptive episodes in several key body systems. Its applications include specific pneumonias, acute sinusitis, acute bacterial exacerbation of chronic bronchitis, complicated and uncomplicated urinary tract infections, kidney infection (pyelonephritis), chronic bacterial prostatitis, and infections of the skin and soft tissues.

The medication is used to address symptom clusters that may become intense or disruptive, such as those related to systemic imbalance (like fever) or localized discomfort and inflammatory states. It is relevant in clinical settings that involve acute or unstable symptom patterns, supporting the body when pathogens create noticeable physiological strain. The overall benefit is that this supportive therapy helps ease the overall symptom burden and contributes to easing the overall symptom load during these symptomatic periods.

“Truxa plays a role in managing symptoms that interfere with daily comfort across multiple acute therapeutic contexts, especially where short-term symptomatic assistance is needed.”

Quick Fact Relief
Relief for Respiratory Symptoms Used in conditions marked by worsening cough and breathing difficulty.
Relief for Urogenital Symptoms Applied for managing discomfort associated with kidney and urinary tract infections.
Relief for Inflammatory Signs May assist with symptoms of redness, pain, and swelling in skin and soft tissue infections.

Eligibility and Restrictions for Use

Who can and cannot use Truxa?

The official regulatory profile for Truxa (Levofloxacin) is defined by a series of mandatory prohibitions and conditional constraints. The medicine is contraindicated and must not be used by patients with a known history of hypersensitivity to levofloxacin or any other quinolone antibacterial agent. Absolute non-eligibility also applies to individuals with a history of epilepsy or past tendon disorders related to previous fluoroquinolone treatment.


Contraindications and Prohibitions

  • Use is contraindicated during pregnancy and while breast-feeding.
  • The standard authorized population is adults (ge 18 years of age). Use in children and growing adolescents (le 18 years) is generally not recommended and is listed as contraindicated in some official labeling.
  • Conditional use is authorized in pediatric patients ge 6 months only for specific, life-threatening indications like Anthrax or Plague, reserved for when no alternatives exist.

Conditional Use and Comorbidity Limitations

Certain populations are eligible only under restricted or conditional use as defined in the official label. This includes patients with impaired renal function, which necessitates adjustment. Use is also restricted in patients concurrently taking corticosteroid drugs due to a significantly increased risk of tendon rupture. Use should be avoided in patients with a history of myasthenia gravis or conditions causing QT interval prolongation.

What should I know about interactions with other medicines?

Truxa Interactions with other medicines and products

This section outlines interactions with other substances that are officially documented in government regulatory prescribing information for Truxa (Levofloxacin).


Documented Interaction Patterns

Certain combinations are subject to restrictions due to risks identified in regulatory labeling. Co-administration with medicinal products known to prolong the QT interval (such as Class IA and Class III antiarrhythmics) is advised against, as this carries a heightened risk of serious cardiac arrhythmias.

Absorption and Clearance Modifiers

Interaction Type Interacting Substances Practical Implication (Regulatory)
Reduced Absorption (Chelation) Multivalent cation-containing products (e.g., antacids with magnesium or aluminum, iron/zinc supplements, sucralfate, buffered Didanosine) Oral Truxa must be administered two hours before or two hours after these products to prevent reduced absorption.
Reduced Clearance Probenecid and Cimetidine These medications reduce the renal clearance of Levofloxacin, leading to increased plasma concentrations of Truxa.

Pharmacodynamic interactions are also documented. Co-use with antidiabetic agents (e.g., insulin) requires monitoring for blood glucose disturbances. Combining Truxa with systemic corticosteroids increases the risk of tendon rupture, a risk noted to be higher in older patients. Furthermore, co-administration with certain NSAIDs may lower the cerebral seizure threshold.

Mechanism of Action

How Truxa Works: Mechanism of Action

Truxa is a monoclonal antibody that initiates its pharmacodynamic activity by engaging the CD20 protein, a specific antigen expressed on the surface of pre-B and mature B-lymphocytes. This antigen binding is the primary molecular interaction, selectively identifying the targeted cells in the peripheral immune system.

The binding of Truxa's Fc region to the B-cell surface simultaneously triggers multiple destructive mechanistic cascades. These include the activation of Complement-Dependent Cytotoxicity (CDC) and the facilitation of Antibody-Dependent Cell-mediated Cytotoxicity (ADCC), which recruit immune effector cells to lyse the tagged B-cells. Additionally, the binding induces a direct intracellular signal leading to programmed cell death (apoptosis) within the B-lymphocyte itself.

The combined actions of CDC, ADCC, and apoptosis produce a sustained depletion of CD20-positive B-lymphocytes from the circulation and lymphoid tissues. This selective clearance influences the dynamics of immune cell populations and the resulting physiological state.

Dosage and Administration Information

How Truxa is Used: Official Administration Guidelines

The usage of Truxa (Levofloxacin) is governed by specific instructions concerning route, dosage, frequency, and duration established for clinical use. This information ensures the standardized administration of the medicine in clinical practice.


Administration Scope

Category Official Administration Instruction
Route of Administration Systemic use is via oral tablet or intravenous (IV) infusion. An ophthalmic solution is also available for local topical use.
Dosing Schedule (Adults) 250 mg, 500 mg, or 750 mg administered once daily (every 24 hours). The dose and duration are specific to the type of infection being addressed.
Timing in Relation to Meals Oral tablets may be taken with or without food.
Preparation Requirements The IV form is for slow intravenous infusion only. It should not be administered as a rapid or bolus injection and must be infused over a period of 60 to 90 minutes, depending on the total dose.

Population and Procedural Adjustments

Dose Adjustments

  • Renal Function: A dose reduction or adjustment in dosing frequency is required for adult patients with impaired renal function (Creatinine Clearance, CLcr leq 50 mL/min). No dose adjustment is required for patients with hepatic impairment.
  • Pediatric Use: Dosing for children is typically limited to specific, severe infections like anthrax or plague, often using a weight-based dose (e.g., 8 mg/kg) administered twice daily (every 12 hours).

Special Procedural Conditions

Oral administration must be separated by at least two hours from multivalent cation-containing products, such as antacids containing magnesium or aluminum, iron salts, or sucralfate, as co-administration may reduce the medicine's absorption. If a dose is missed, it should be taken as soon as possible, but if the next scheduled dose is less than 8 hours away, the missed dose is typically skipped to maintain the once-daily schedule.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Truxa

Evidence for use in COVID-19

Truxa was studied for use in people diagnosed with COVID-19. Research primarily included Randomized Controlled Trials (RCTs) and observational studies. These studies examined patients in two main groups: non-hospitalized adults with milder symptoms, and hospitalized adults with varying degrees of illness. Researchers focused on outcomes such as mortality rates, duration of hospitalization, and the time it took for symptoms to resolve. Findings describe patterns observed in the studies related to recovery time and the reported length of hospital stays. The data show patterns related to symptom evolution over a short period. Research provides context but not individual predictions.

Evidence for use in Hospitalized Pneumonia

Truxa was evaluated in research for hospitalized pneumonia, including community-acquired and hospital-acquired forms. The primary research consists of Randomized Controlled Trials and systematic reviews. These studies examined hospitalized adults, including those in the intensive care unit (ICU). Researchers monitored outcomes such as all-cause mortality, measured success against the infection, and how quickly patients could be discharged. Studies report how symptoms evolved in the observed populations and the measured rates of microbiological success. Evidence quality varies across studies, and there is limited information for long-term outcomes following recovery.

Long-term Studies and Follow-up

For both conditions, the available research is limited in assessing the long-term effects of Truxa. The studies focused on the acute phase of the illnesses, meaning the follow-up durations were limited to short- and intermediate-term timeframes. Long-term effects are not fully established, and future research is ongoing to understand delayed effects.

What is Still Uncertain About Truxa

The research landscape highlights what is known — and what is still uncertain. Evidence is limited in a few key areas, including: data for certain groups remain insufficient (e.g., children or pregnant individuals), findings were mixed in some studies due to population variability, and comparative evidence is lacking against every other possible treatment choice. These limitations mean that while Research shows what has been observed so far, it does not provide a complete picture.

Key Studies & References

  1. Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials
  2. WHO Therapeutics and COVID-19: living guideline (Conditional Recommendation for Remdesivir)

Frequently Asked Questions (FAQ)

Common questions about Truxa (FAQ)


Q: How long does it typically take for Truxa to start working?

Official product information suggests that noticeable improvement in symptoms may begin within 24 to 72 hours (one to three days) of starting treatment. As an antibiotic, the medication begins its action against the bacteria shortly after the first dose.

Q: What are the most common side effects people report when taking Truxa?

According to regulatory documents, the most frequently reported adverse reactions, occurring in three percent or more of patients, include nausea, headache, diarrhea, insomnia (difficulty sleeping), constipation, and dizziness. This list summarizes the effects commonly observed in clinical studies.

Q: Can Truxa be taken with standard pain relievers like ibuprofen or acetaminophen?

Official information advises caution when using Truxa alongside certain non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, as this may lower the cerebral seizure threshold. While there is generally no direct interaction with acetaminophen listed on the primary regulatory label, all over-the-counter medicines should be reviewed with a healthcare provider.

Q: Is it okay to drink alcohol while I am on Truxa?

While regulatory documents may not strictly prohibit alcohol, official warnings note that consumption can increase the risk of adverse central nervous system (CNS) effects, liver strain, and cardiovascular issues associated with this medication. Given the risks, avoiding alcohol consumption during the course of treatment is generally advised by healthcare professionals.

Q: How long can I stay on Truxa safely?

The required length of treatment is specific to the infection being treated and is determined by a healthcare provider, typically ranging from 3 to 14 days. Official labels do not provide a general maximum duration for all uses, as the duration is based on the specific infection.

Q: What does the research say about the long-term effectiveness of Truxa?

Official research summaries indicate that long-term follow-up is limited and effects beyond the acute phase are not fully established. Additionally, regulatory warnings note that some serious adverse effects, such as peripheral neuropathy (nerve damage) or tendon rupture, can persist or occur months after the drug is stopped.

Q: Is it normal to feel a bit nauseous when first starting Truxa?

Yes, regulatory data indicates that nausea is one of the most common adverse reactions reported in clinical trials. It is frequently observed, especially when patients first begin taking the medication.

Q: Can Truxa make me feel more tired or drowsy?

Official information lists dizziness as a common side effect. Because of the potential for impaired alertness, regulatory bodies advise caution regarding activities like driving or operating machinery until the patient knows how the medication affects them.

Q: What happens if I stop taking Truxa suddenly?

General guidance for antibiotics advises that stopping the medication abruptly, even if symptoms improve, may result in the failure to fully eliminate the infection. This could lead to the recurrence of infection or contribute to the development of antibiotic resistance, according to general antibiotic use guidance.

Q: Are there any known drug-disease interactions with Truxa?

Yes, official warnings advise that Truxa should be avoided or used with caution in patients with certain pre-existing conditions. These include a history of myasthenia gravis, epilepsy, or known conditions that prolong the QT interval (a measure of heart rhythm).

Q: What is the shelf life of Truxa after the bottle is opened?

Regulatory storage information specifies that tablets should be kept in a tightly closed container between 20°C and 25°C to maintain stability. However, official documents do not provide a specific duration of use after the container is opened, so the original expiration date on the package should be followed.

Q: Is it possible to be allergic to Truxa?

Yes, official warnings note that serious hypersensitivity reactions, which can be potentially fatal, may occur, sometimes after the first dose. The medication is contraindicated (must not be used) in anyone with a known history of allergy to Truxa or any other quinolone antibiotic.

Q: Can Truxa cause mood swings or changes in behavior?

Official regulatory warnings list potential Central Nervous System effects, including anxiety, depression, and psychotic reactions. Patients should be aware that these changes in mood or behavior have been reported in the product safety profile.

Q: Where can I find reliable, official information about Truxa?

Reliable and authoritative information about this medication can be found on government-run health authority websites. These sources include the U.S. National Institutes of Health (NIH), the U.S. Food and Drug Administration (FDA) through DailyMed, and the European Medicines Agency (EMA).

Q: Why is Truxa sometimes prescribed 'off-label'?

Regulatory bodies acknowledge that healthcare providers may prescribe a drug for an unapproved indication based on sound medical judgment and supporting clinical data. The FDA has restricted the approved use of this drug for some less severe infections, meaning it is reserved for cases where alternative treatment options are not suitable.

Q: Will taking Truxa make me more sensitive to the sun?

Yes. Official product information advises patients to avoid unnecessary or prolonged exposure to sunlight or artificial ultraviolet light, such as tanning beds. This medication can cause photosensitivity, which increases the risk of sunburn or other skin reactions.

Q: What should I do if the side effects of Truxa are bothering me?

For common, non-serious side effects, patients should discuss them with their healthcare provider if they are severe or persistent. For serious reactions (like tendon pain or swelling), official instructions require the patient to stop the medication immediately and seek urgent medical attention.

Q: Can Truxa be crushed or split if it's hard to swallow?

While the oral tablet formulation is generally designed to be swallowed whole, patient counseling materials sometimes advise that the tablet may be crushed. A patient should always verify with their pharmacist or prescribing clinician whether their specific formulation can be modified.

Q: Why is Truxa taken at a specific time of day?

The dosing schedule is once daily (every 24 hours), and a consistent time helps maintain the proper drug concentration. The timing also helps ensure separation by at least two hours from products that contain multivalent cations, preventing absorption issues.

Q: Can environmental factors affect how well Truxa works?

Yes, official labeling specifies strict storage requirements for both the tablets and solutions, including specific temperature ranges and keeping the container tightly closed. This ensures the stability and effectiveness of the product.

Q: Can Truxa interact with herbal teas or remedies?

General patient counseling materials advise informing a healthcare provider of all herbal products, supplements, and teas being consumed. Some herbal remedies, particularly those containing minerals or cations, can reduce the absorption of Truxa, making it less effective.

Q: How does Truxa impact the immune system?

This medication is primarily an antibiotic used to kill bacteria. However, its mechanism of action involves the selective depletion of B-lymphocytes (a type of white blood cell), which are part of the body's adaptive immune response.

Q: Is Truxa the same type of medicine as [similar drug name]?

Truxa's active ingredient, Levofloxacin, belongs to the fluoroquinolone class of antibiotics, which includes other related medicines. It is specifically classified as a third-generation fluoroquinolone with a chemical structure related to Ofloxacin.

Q: How often do I need to take Truxa?

The standard dosing for adults is once daily, meaning a single dose every 24 hours. The specific frequency and duration will be determined by the type of infection being treated and the patient's individual health status.

Q: What should I do if I miss a dose of Truxa?

If a dose is missed, it should be taken as soon as possible. However, official guidelines state that if the time until the next scheduled dose is less than 8 hours, the missed dose is typically skipped to maintain the once-daily schedule.

Q: Can Truxa interact with common vitamins or supplements like Vitamin D?

The absorption of this medication is reduced if it is taken within two hours of multivalent cation-containing products, such as supplements containing minerals like iron, zinc, or magnesium. This interaction should be discussed with a healthcare provider.

Q: How quickly do the side effects of Truxa usually go away after stopping the drug?

The time it takes for milder side effects to resolve is not specified in regulatory documents. However, official warnings note that serious adverse effects, such as peripheral neuropathy (nerve damage) or tendon rupture, may be potentially irreversible and can occur or persist long after treatment has been stopped.

Q: Are there any lifestyle changes that can improve Truxa's effectiveness?

Official instructions focus on administration timing, requiring separation by at least two hours from all multivalent cation-containing products (such as antacids or certain mineral supplements) to ensure proper absorption and full effectiveness.

Q: If I feel better, can I stop taking Truxa before the prescribed time?

General guidance for antibiotics advises against stopping the medication even if symptoms resolve. Completing the entire course is essential to ensure the infection is fully cured and to minimize the risk of developing bacterial resistance.

How should Truxa be stored and disposed of?

How to Store and Dispose of Truxa (Levofloxacin)

The official storage and disposal requirements for Truxa vary by its formulation and are mandatory for product stability and safety.

Storage Conditions

Detail Requirement
Film-Coated Tablets Store at 20°C to 25°C (68°F to 77°F); keep container tightly closed.
Infusion/Ophthalmic Solutions Store within 15 C to 30 C range; Do not freeze.
Child Safety Must be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired Truxa must not be disposed of via wastewater or regular household trash. Disposal must be performed according to local requirements for pharmaceutical products, such as authorized drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Truxa found in:

A-Z Index: